Found 120 matching trials
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation NA This is an open, one-arm study to evaluate the safety and efficacy of mRNA ...
Show More Location
Multiple Locations
Learn More & Join Trial
Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC) PHASE2 This is a single-arm, open-label and exploratory clinical study of Anlotini...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer PHASE2 This study is a single-center, randomized controlled, phase II clinical tri...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial PHASE3 This is a randomized, controlled clinical trial based on prior exploratory ...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer PHASE2 Study design: Prospective, single-arm, single-center phase II clinical stud...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Study of GC101 TIL in Advanced Melanoma PHASE2 98 participants will be randomly assigned 1:1 to the experimental group and...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors PHASE1 To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial
Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial PHASE2 This phase II, multicenter, single-arm, open-label study evaluates first-li...
Show More Location
West China Hospital, Chengdu, Sichuan 610000
Learn More & Join Trial
Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma PHASE2 This is a single-arm phase II clinical trial to evaluate the initial effica...
Show More Location
West China Hospital
Learn More & Join Trial